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Background: In the Republic of Congo, with two massive outbreaks of Chikungunya observed this decade, little is known about the insecticide resistance profile of the two major arbovirus vectors Aedes aegypti and Aedes albopictus. Here, we established the resistance profile of both species to insecticides and explored the resistance mechanisms to help Congo to better prepare for future outbreaks.
Methods: Immature stages of Ae. aegypti and Ae. albopictus were sampled in May 2017 in eight cities of the Republic of the Congo and reared to adult stage. Larval and adult bioassays, and synergist [piperonyl butoxide (PBO)] assays were carried out according to WHO guidelines. F1534C mutation was genotyped in field collected adults in both species and the polymorphism of the sodium channel gene assessed in Ae. aegypti. 
Results: All tested populations were susceptible to temephos after larval bioassays. A high resistance level was observed to 4% DDT in both species countrywide (21.9–88.3% mortality). All but one population (Ae. aegypti from Ngo) exhibited resistance to type I pyrethroid, permethrin, but showed a full susceptibility to type Ⅱ pyrethroid (deltamethrin) in almost all locations. Resistance was also reported to 1% propoxur in Ae. aegypti likewise in two Ae. albopictus populations (Owando and Ouesso), and the remaining were fully susceptible. All populations of both species were fully susceptible to 1% fenitrothion. A full recovery of susceptibility was observed in Ae. aegypti and Ae. albopictus when pre-exposed to PBO and then to propoxur and permethrin respectively. The F1534C kdr mutation was not detected in either species. The high genetic variability of the portion of sodium channel spanning the F1534C in Ae. aegypti
Conclusions: Our study showed that both Aedes species were susceptible to organophosphates (temephos and fenitrothion), while for other insecticide classes tested the profile of resistance vary according to the population origin. These findings could help implement better and efficient strategies to control these species in the Congo in the advent of future arbovirus outbreaks. 

















Dengue virus (DENV), Zika virus (ZIKV), yellow fever virus (YFV) and chikungunya virus (CHIKV) are Aedes-borne viruses of medical concern in tropical and subtropical regions. During the last two decades, diseases caused by these viruses are increasingly reported in several regions of the world including in Central Africa  ADDIN EN.CITE [] where the epidemics were formerly considered as scarce (apart for YFV). These diseases are transmitted to humans through the bite of an infected mosquito belonging to the Aedes genus. Both urban vectors, Aedes aegypti Linnaeus 1762 and Aedes albopictus (Skuse) 1894 are well established in Africa where Ae. aegypti is native []. Ae albopictus, which originated from South-East Asia forests, was reported for the first time in Central Africa in the early 2000s in Cameroon [] and has since progressively colonized almost all countries in the region including the Republic of the Congo where it tends to supplant the resident species Ae. aegypti in sympatric areas  ADDIN EN.CITE []. During the chikungunya outbreak reported in the Republic of the Congo in 2011 with more than 11 000 cases, CHIKV was detected in Ae. aegypti and Ae. albopictus  ADDIN EN.CITE [, ]. Aedes albopictus was suspected as the main vector during the recent chikungunya outbreak reported in 2019 in the Republic of the Congo  ADDIN EN.CITE []. It was demonstrated that both Ae. aegypti and Ae. albopictus from Brazzaville (Congo) are able to transmit YFV []
In the absence of effective vaccines (apart for YFV) and specific treatments against these viruses, vector control remains the cornerstone to prevent and control outbreaks. Existing vector control strategies include destruction of breeding sites and insecticide-based interventions. Indeed, the use of larvicides to treat water storage containers such as barrels and space spraying of adulticides in emergency situations can help to reduce the density of  Aedes mosquitoes  ADDIN EN.CITE [, ]. Unfortunately, the emergence of insecticide resistance significantly hampers the efficacy of insecticides to control pests. Thus, many vector control programmes are facing the challenge from the development of insecticide resistance in Ae. aegypti and Ae. albopictus. Both major vectors have been found to be resistant to several classes of insecticides in different regions across the world with significant variation according to the population’s origin and the insecticide class including pyrethroids, organophosphates and organochlorines  ADDIN EN.CITE []. 








Larval bioassays were performed according to standard WHO guidelines  ADDIN EN.CITE [, ] using F1/F2 larvae. The susceptibility of larvae was evaluated against technical-grade temephos (97.3%; Sigma Aldrich-Pestanal®, Germany). First, stock solutions and serial dilutions were prepared in 95% ethanol and stored at 4 ℃. Five doses of concentration ranging from 0.0025 to 0.006 mg/L have been used for the assay. Eighty to 100 larvae per concentration (with three to four replicates, depending on the sample and the number of larvae available) were tested. Third late instar larvae of each species were placed in plastic cups containing 99 mL of tap water, and 1 mL of insecticide solution at the required concentration was added. Control groups were run systematically with larvae exposed to 1 ml of ethanol. No food was provided to larvae during the bioassays, which were run at 28 ± 2 ℃ and 80 ± 10% relative humidity. Mortality was scored after 24 h of exposure to the insecticide. Mortality rates were corrected with Abbott’s formula [] when the mortality of controls was > 5%. 
All data were analysed with Win DL v. 2.0 software []. Lethal concentrations (LC50 and LC95) were estimated with their 95% confidence intervals (CIs). Resistance ratios (RR50 and RR95) were calculated by comparing the LC50 and LC95 for each species with those of susceptible strain, as RR50 = LC50 of studied population/LC50 susceptible strain and RR95 = LC95 of studied population/LC95 reference strain. A mosquito population was considered susceptible when RR50 was less than 2, potentially resistant when RR50 was between 2 and 5, and resistant when RR50 was over 5 [].
Adult bioassays
Insecticide susceptibility bioassays were performed with 3 to 5 day old unfed Ae. aegypti and Ae. albopictus mosquitoes according to the standard WHO guideline []. Six Ae. albopictus populations and two Ae. aegypti populations were used for the assays. Four replicates of 20 to 25 mosquitoes from G1/G2 generation per tubes were tested to five insecticides: 4 DDT (organochlorine), 1 propoxur  (carbamate), 1% fenitrothion (organophosphate), 0.05 deltamethrin  and 0.025 permethrin (pyrethroids). Insecticide-impregnated papers were supplied by Liverpool School of Tropical Medicine. Mortality was recorded 24 h later and mosquitoes alive and dead after exposure 24 h were stored in RNA later (Sigma, Netherland) and silica gel respectively.
Synergist assay
In order to investigate the potential role of oxidases in the metabolic resistance mechanism, synergist assay was performed when the number of mosquitoes permitted using 4 piperonyl butoxide (PBO). 3–5 day-old adults were pre-exposed for one hour to PBO-impregnated papers and after that immediately exposed to the selected insecticide. Mortality was scored 24 h later and compared to the results obtained with each insecticide without synergist according to the WHO standards [].
Investigating of F1534C mutation using allele specific PCR
Genomic DNA was extracted from around 30 individuals (G0) of Ae. aegypti and Ae. albopictus per populations using the Livak protocol ([]. These DNA were used to genotype the F1534C mutation which was found mostly widespread across the world in Ae. aegypti and associated with type I pyrethroid resistance and DDT resistance. Experiments were performed using allele specific (AS) PCR assays previously described  ADDIN EN.CITE []. As the genomic sequence of the sodium channel gene spanning the ⅢS6 segment between both species is highly conserved, we employed the same AS-PCR previously designed for the F1534C variation in Ae. aegypti  ADDIN EN.CITE [] also for Ae. albopictus. Each PCR was performed using a Gene Touch thermal cycler (Bulldog Bio, Portsmouth, USA) in a 15 μl volume containing: 1 μl of DNA sample, 0.4 units of Kapa Taq DNA polymerase, 0.12 μl of 25 mmol/L dNTPs (0.2 mmol/L), 0.75 μl of 25  mmol/L MgCl2 (1.5  mmol/L), 1.5 μl of 10× PCR buffer (1×), 0.51 μl of each primers (0.34  mmol/L).  The amplification consisted of 95 °C for a 5 min heat activation step, followed by 35 cycles of 94 °C for 30 s, 55 °C (60 °C for Ae. albopictus) for 30 s and 72 °C for 45 s with a 10 min final extension step at 72 °C. PCR products were detected by agarose gel electrophoresis in Tris-Acid-EDTA buffer (TAE). The 3% gel was prepared with Midori green, staining dye, and visualized with the aid of UV light.
Polymorphism of the voltage-gated sodium channel (VGSC) gene in Ae. aegypti 




Due to the limited number of larvae available, larval bioassays were performed for two Ae. aegypti populations from Ngo and Brazzaville, and one Ae. albopictus population from Brazzaville. Analysis revealed that for both Aedes species and populations tested, RR50 and RR95 were less than 2 suggesting that Ae. aegypti and Ae. albopictus of these locations are susceptible to temephos (Table 1).

Insecticide resistance profile in adults Aedes
Assays performed with laboratory susceptible strains confirmed that Ae. albopictus (VCRU), Ae. aegypti (New Orleans) and Ae. aegypti (Benin) were totally susceptible to insecticides tested except to DDT for which 80.68% (VCRU strain) and 98.75% (New Orleans strain) mortality rates were found, respectively. The mortality rate in controls was less than 5%.
Resistance pattern for Ae. aegypti
Two Ae. aegypti populations from Brazzaville (the major city of the country) and Ngo were tested for resistance to five insecticides (Fig.2). In Brazzaville population, resistance was observed against the organochlorine DDT with a low mortality rate of 41.2%. Resistance was also observed against pyrethroids, notably permethrin (type I) with 71.0% mortality registered whereas mortality was higher (95.3%) for deltamethrin (Type Ⅱ). Noticeably, this Ae. aegypti population of Brazzaville is resistant to carbamates with 69.0% mortality for propoxur. However, full susceptibility to the organophosphate fenitrothion was reported in this population in line with the susceptibility observed at the larval stage against the other organophosphate, temephos. The other population from Ngo displayed a moderate resistance level to DDT (88.3%) and a probable resistance to propoxur (91.0%). In contrast to Brazzaville, the Ngo population was fully susceptible to both types of pyrethroids highlighting a variation of susceptibility profile of Ae. aegypti across Congo. It also exhibited a full susceptibility toward the organophosphate fenitrothion. 
Resistance pattern for Ae. albopictus
For Ae. albopictus, six populations were analysed: Brazzaville, Lefini, Ouesso, Gamboma, Makoua and Owando (Fig. 3). Analysis revealed that all the populations tested were resistant to DDT with the mortality rate ranging from 21.9% in Owando to 88.3% in Gamboma. A similar pattern was observed for type I pyrethroid permethrin with mortality rates varying from 40.5% in Owando population to 92.8% in Ouesso. However, for the type Ⅱ pyrethroid deltamethrin, a probable resistance was reported in Lefini with a mortality rate of 94.4% whereas the other five populations were found susceptible with mortality rates ranging from 98.0% (Makoua, Gamboma and Owando) to 100.0% (Brazzaville and Ouesso). A moderate resistance was detected against the carbamate propoxur in Owando (90.0% mortality) and Ouesso (95.5%) whereas the remaining populations were fully susceptible. As for Ae. aegypti populations, a full susceptibility to the organophosphate fenitrothion was reported in all populations. 

Synergist assay with PBO
Results from the synergist assay in the Ae. albopictus population from Brazzaville resistant to permethrin showed a full recovery of susceptibility after PBO pre-exposure (81.5 ± 3.3% mortality without PBO pre-exposure vs 100 ± 0.0% mortality after PBO pre-exposure, P <0.001) suggesting that cytochrome P450 enzymes play a major role in permethrin resistance in this population.
Similar analysis for the Ae. aegypti population from Brazzaville showed a full recovery of susceptibility after PBO pre-exposure for the propoxur (69.0 ± 6.1% mortality without pre-exposure versus 100 ± 0.0% mortality after PBO pre-exposure, P<0.001) suggesting that cytochrome P450 enzymes  also play a major role in carbamate (propoxur) resistance in this population (Fig. 3). 
F1534 genotyping 
After genotyping 64 specimens of Ae. aegypti from three locations and 136 specimens of Ae. albopictus from six locations no resistant individual was detected in both species with 100% homozygote F1534 mosquitoes detected. 
Genetic diversity of VGSC gene in Ae.aegypti
Twenty seven field collected Ae. aegypti from three locations were successfully sequenced for an 198 bp fragment of the VGSC gene spanning  the codon 1534. Analysis confirmed the absence of F1534 mutation. Overall, a high genetic diversity is observed for this fragment with 10 polymorphic sites, 12 haplotypes, eight synonymous and two non-synonymous mutations associated with a high haplotype diversity (0.823) and relatively low nucleotide diversity (0.008) (Table 2). This high diversity is also supported by the pattern of TCS haplotype network with haplotypes separated with several mutational steps suggesting a lack of selection in this locus although three haplotypes are predominant. The predominant haplotype H4 is found in all three populations (Fig. 4a). A maximum likelihood (ML) tree of the sequences analysed confirms a high diversity with the potential three clusters (Fig. 4b). Overall, all the statistics estimated were negatives (D = -0.79, Fs = -3.82, and F* = -0.19), but not statistically significant (Table 2). Negative values for these indices indicate an excess of rare polymorphisms in a population and suggest either population expansion or background selection []
Discussion
This study investigated for the first time the insecticide profile of Ae. aegypti and Ae. albopictus in the Republic of the Congo and explored the resistance mechanism involved. Analysis of larval bioassays revealed that all Ae. aegypti and Ae. albopictus samples tested were susceptible to temephos. This result is consistent  with the previous result obtained in Central Africa notably in Cameroon [], Gabon [] and Central African Republic  ADDIN EN.CITE [].  Nonetheless, the resistance to this compound has been reported in several countries such as in Brazil  ADDIN EN.CITE [, ], Malaysia  ADDIN EN.CITE [], Thailand [] and Carpe Verde  ADDIN EN.CITE [] for Ae. aegypti and in Greece  ADDIN EN.CITE [], Malaysia  ADDIN EN.CITE [] and Thailand [] for Ae. albopictus. Selection of the resistance results from extensive and long-term use of the product incriminated, meanwhile in our knowledge, temephos had never been used in vector control programs in Central Africa which probably explains the full susceptibility reported in both species. 
Both adult populations of Ae. aegypti tested were resistant to DDT. A similar pattern of resistance to DDT was shown in Ae. albopictus populations. A decreasing susceptibility of the Ae. aegypti population from Brazzaville towards DDT was already mentioned in 1970s [], suggesting that this resistance may have resulted from a continuing selection pressure on Aedes populations as suggested previously  ADDIN EN.CITE []. DDT resistance has repeatedly been reported in Ae. aegypti  ADDIN EN.CITE [, , , ] and Ae. albopictus  ADDIN EN.CITE [, ]. Both species exhibited a significant level of resistance against the type I pyrethroid permethrin, loss of susceptibility to this insecticide was previously reported in neighbouring countries such as Cameroon []. However, the fact that one population of Ae. aegypti remains fully susceptible suggests that pyrethroid resistance has not yet spread nation-wide in the Republic of the Congo. On the other hand, for the type Ⅱ pyrethroid, deltamethrin, no resistant population was found despite a reduced susceptibility reported in some populations in both species. The striking difference of the resistance pattern in both pyrethroids tested could be due to the fact diagnostic dose used for deltamethrin 0.05% is higher than 0.03% recommended for Aedes [].  The reduced  susceptibility to deltamethrin and resistance to permethrin observed in both species may poses a serious threat for vector control programmes, because pyrethroids are mainly recommended for the control of adult Aedes mosquitoes  ADDIN EN.CITE [, ]. A loss of susceptibility was reported also to propoxur with moderate level of resistance in Ae. aegypti population from Brazzaville. Similar patterns of insecticide resistance profile found in this study were reported in several countries in Africa such as Burkina-Faso  ADDIN EN.CITE [], Central African Republic  ADDIN EN.CITE [], and Cameroon []. The source of selection driving the observed resistance to DDT and permethrin as well as the reduced susceptibility to deltamethrin and propoxur in the Republic of the Congo as in other central African countries remains unclear notably as the use of insecticides against Ae. aegypti and Ae. albopictus is limited in the region  ADDIN EN.CITE [, ]. As suggested previously  ADDIN EN.CITE [, ], domestic used of insecticides through the indoor spraying and impregnating bed nets, and agriculture use could be the main source of resistance selection in Aedes vectors in Central Africa. The higher resistance level to DDT observed in Ae. aegypti in the Republic of the Congo would be probably a consequence of the intense DDT spraying in the 1950s and 1960s as part of the malaria elimination campaign as suggested previously []. Meanwhile, for Ae. albopictus which was first reported in the Republic of the Congo in 2011 during the chikungunya outbreak in Brazzaville  ADDIN EN.CITE [], we cannot exclude the possibility that the invading populations possessed the resistance background, as suggested  previously  ADDIN EN.CITE [, ].
A full recovery of susceptibility to permethrin and propoxur was reported in Ae. albopictus and Ae. aegypti from Brazzaville respectively after pre-exposure to PBO synergist. This result indicates that the cytochrome P450 monooxygenases are playing the main role in the observed resistance which is consistent with previous data from the sub-region  ADDIN EN.CITE [, ]. None of the specimens of Ae. aegypti or Ae. albopictus genotyped possesses the 1534C allele suggesting this mutation is not currently involved in pyrethroid resistance in populations of both species in Congo. Nevertheless, this mutation known as most widely distributed in Aedes aegypti  ADDIN EN.CITE [] has been detected in sample from West Africa in Ghana  ADDIN EN.CITE [] and Burkina-Faso  ADDIN EN.CITE []. This mutation has also been detected in Ae. albopictus from several countries outside Africa like Brazil, India, Greece, Singapore and China [].  The high genetic diversity of the VGSC portion spanning codon 1534 further supports the absence of kdr mutation in Ae. aegypti
in Congo as shown by the ML phylogenetic tree and TCS haplotype network. This is similar to the situation where kdr in absent as in Ae. albopictus population from Malaysia   ADDIN EN.CITE []  or the malaria vector Anopheles funestus   ADDIN EN.CITE [, ]. It will be interesting to extend this work in other locations throughout the country, genotype other mutations such as 1016 and 410 which have been found implicated in kdr resistance in Ae. aegypti  ADDIN EN.CITE [, , ] and investigate the genes involved in metabolic resistance in both Aedes species. 

Conclusions
Our study showed that both Ae. aegypti and Ae. albopictus species were susceptible to organophosphates (temephos and fenitrothion), while for other insecticide classes tested the profile of resistance vary according to the population sampled. This first countrywide resistance profile to main insecticide classes in both Aedes vectors in the Republic of Congo should enable this country to quickly implement insecticide-based control interventions in the event of future outbreaks. The full susceptibility of both species to organophosphates at both larval and adult stages makes this insecticide class very suitable for control nation-wide. 
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Figure 1. Map of the Republic of the Congo showing the sampling sites.
Figure 2. Mortality rates of adult Aedes aegypti from the Republic of the Congo 24 h after exposure to insecticides alone or with 1 h pre-exposure to synergist. a, Brazzaville; b, Ngo. Error bars represent standard error of the mean. DDT, dichlorodiphenyltrichloroethane. PBO, piperonyl butoxide.

Figure 3. Mortality rates of adult Aedes albopictus from the Republic of the Congo 24 h after exposure to insecticides alone or with 1 h pre-exposure to synergist. a, Brazzaville; b, Makoua; c, Ouesso; d, Leffini; e, Owando; f, Gamboma. Error bars represent standard error of the mean. DDT, dichlorodiphenyltrichloroethane. PBO, piperonyl butoxide.








Table 1: Larval bioassays of Aedes aegypti and Ae. albopictus with temephos
Strains and sites	N	LC50 (mg/L) (95% CI)	RR50	LC95 (mg/L) (95% CI)	RR95
Ae. aegypti					
Reference strain	531	0.00268 (0.0025–0.0028)		0.00463 (0.004 3 –0.0051)	
Ngo	410	0.00259 (0.0024–0.0028)	0.96	0.00443 (0.0040 –0.0051)	0.95
  Brazzaville	423	0.00413 (0.004 –0.0043)	1.54	0.00528 (0.0050 –0.0057)	1.14
Ae. albopictus					
Reference strain	574	0.00310 (0.0013 –0.0041)		0.0068 (0.0051 –0.0209)	






Table 2. Summary statistics for the polymorphism of the VGCS portion in Aedes aegypti from the Republic of the Congo.
Locality	2n	Hp	S	HpD	syn	nonsyn	π (k)	D	Fs	F*
Brazzaville	18	5	4	0.601	3	1	0.005(0.935) 	-0.588 ns	-1.430 ns	-0.770 ns
Gamboma	16	7	8	0.875	7	1	0.011(2.133)	-0.415 ns	-1.519 ns	0.121 ns
Ngo	20	6	4	0.742	4	0	0.007(1.384) 	0.659 ns	-0.285 ns	1.133 ns
Total	54	12	10	0.823	8	2	0.008(1.579) 	-0.792ns	-3.82 ns	-0.193 ns

N, Number of sequences analysed (2n); Hp, Number of haplotypes; S, Number of segregating sites; syn, Synonymous mutation; nonsyn, Non-synonymous mutation; HpD, Haplotypes diversity; π, Nucleotide diversity; K, Average of number of nucleotide difference; Tajima's D and Fu's Fs and Fu and Li F* statistics; ns, Non-significant.
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S1 Fig. Map of the Republic of Congo showing the resistance status of Aedes aegypti and Ae. albopictus to insecticide. a, Aedes albopictus; b, Ae. aegypti.



